MedTrace Logo

Trial Estimating the Efficiency of the Light Therapy in Brain Trauma Sequel Fatigue

NCT02420275 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-12-15

No results posted yet for this study

Summary

After a brain injury (BI) , patients complain in particular about sequel fatigue. This symptom affects about 50 % of the patients; it is severe, with a repercussion on quality of life, reeducation and occupational reintegration, and persists often at a distance of the accident. The investigators' hypothesis is that patients who presented a severe BI could benefit from a treatment by withe blue enriched bright light in order to improve fatigue and quality of life.

Conditions

  • Diffuse Brain Injury

Interventions

OTHER

placebo

THIS GROUP WILL RECEIVE NO BRIGHT LIGHT

DEVICE

"Luminette",Lucimed Belgium

THIS GROUP WILL RECEIVE BLEU LIGHT ENRICHIDED IN WITHE BRIGHT LIGHT

Sponsors & Collaborators

  • Fondation Garches

    collaborator OTHER

  • Centre d'Investigation Clinique et Technologique 805

    lead OTHER

Principal Investigators

  • MARIA ANTONIA QUERA SALVA, MD PhD · RAYMOND POINCARE HOSPITAL

  • SARAH HARTLEY, MD · RAYMOND POINCARE HOSPITAL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-11
Primary Completion
2017-12-01
Completion
2017-12-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02420275 on ClinicalTrials.gov